SCHEMBL7412031

SCHEMBL7412031

CC(C)CC(C(=O)NC(CC(N)=O)CC(=NN)OC(C)(C)C)C(=O)NC(CCC(N)=O)C(=O)Nc1cccc(Oc2ccccc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 1/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC3 O15379 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
MMP8 P22894 2/20 0.37
SCN9A Q15858 1/20 0.36
PSMB5 P28074 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CASP1 P29466 1/20 0.35
CASP3 P42574 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412028 0.81 REN (0.38) RENHDAC4HDAC1HDAC3HDAC7
SCHEMBL7412037 0.81 REN (0.38) RENHDAC4HDAC1HDAC3HDAC7
SCHEMBL7412858 0.79 CASP1 (0.40) MMP8PSMB5CASP1CASP3CASP6
SCHEMBL7409752 0.77 MMP3 (0.40) HDAC4HDAC1HDAC3HDAC7HDAC2
SCHEMBL7406281 0.76 HDAC4 (0.39) RENHDAC4HDAC1HDAC3HDAC7
SCHEMBL7401088 0.76 REN (0.36) RENHDAC4HDAC1HDAC3HDAC7
SCHEMBL7401090 0.76 REN (0.36) RENHDAC4HDAC1HDAC3HDAC7
SCHEMBL7401092 0.76 REN (0.36) RENHDAC4HDAC1HDAC3HDAC7
SCHEMBL7408148 0.73 MMP3 (0.44) MMP8CASP1SIRT5MMP13MMP3
SCHEMBL7406574 0.73 CASP3 (0.52) MMP8CASP3CASP7CASP6CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076968-A1 MALONATES AS INHIBITORS OF THE ICE/CED-6 FAMILY OF CYSTEINE PROTEASES NOVARTIS AG (CH) 2002-10-03 WO disclosed